IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSATI, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.468
NA - Nord America 2.455
AS - Asia 504
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
SA - Sud America 1
Totale 5.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.453
IE - Irlanda 526
IT - Italia 498
SE - Svezia 493
UA - Ucraina 403
HK - Hong Kong 216
VN - Vietnam 175
FI - Finlandia 129
DE - Germania 114
RU - Federazione Russa 95
CN - Cina 67
GB - Regno Unito 58
RO - Romania 41
FR - Francia 31
BE - Belgio 28
TR - Turchia 23
AT - Austria 13
CH - Svizzera 11
UZ - Uzbekistan 11
GR - Grecia 9
EU - Europa 7
NL - Olanda 7
PL - Polonia 6
CI - Costa d'Avorio 5
LB - Libano 4
CZ - Repubblica Ceca 3
CA - Canada 2
JP - Giappone 2
SG - Singapore 2
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
Totale 5.440
Salva come PNG Salva come JPEG
Città #
Chandler 581
Dublin 526
San Mateo 341
Hong Kong 216
Perugia 197
Dong Ket 175
Jacksonville 154
Ann Arbor 143
Medford 107
Princeton 106
Wilmington 82
Altamura 69
Andover 69
Des Moines 51
Lawrence 49
Beijing 46
Bucharest 40
Saint Petersburg 40
Woodbridge 36
Helsinki 33
Ashburn 28
Brussels 28
Norwalk 21
New York 20
Boardman 18
Izmir 18
Dearborn 15
Falls Church 15
Los Angeles 15
Foligno 14
Houston 12
Assisi 9
Moscow 9
Milan 8
Redwood City 8
San Paolo di Civitate 8
Tavernelle 8
Auburn Hills 7
Rome 7
Piediluco 6
Abidjan 5
Den Haag 5
Denizli 5
Redmond 5
Vienna 5
Bastia 4
Florence 4
Frankfurt Am Main 4
Guangzhou 4
Hanover 4
Shanghai 4
Ancona 3
Bologna 3
Civitanova Marche 3
Collazzone 3
Hebei 3
Nanning 3
San Diego 3
Santi Cosma E Damiano 3
Bagnoli Di Sopra 2
Bettona 2
Biancavilla 2
Civitavecchia 2
Dallas 2
Fremont 2
Lausanne 2
Macerata 2
Melissa 2
Mirano 2
Molfetta 2
Selargius 2
Simi Valley 2
Tappahannock 2
Tokyo 2
West Jordan 2
Amsterdam 1
Aosta 1
Baotou 1
Bekasi 1
Bergamo 1
Bollate 1
Brentford 1
Cambridge 1
Campobasso 1
Catania 1
Cerro Maggiore 1
Copenhagen 1
Curtarolo 1
Faenza 1
Fairfield 1
Groningen 1
Jinan 1
Kiev 1
Klaipeda 1
L'aquila 1
Lappeenranta 1
Latina 1
London 1
Lucca 1
Ludwigshafen 1
Totale 3.465
Salva come PNG Salva come JPEG
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 180
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 120
Activity inhibition of cytolytic lymphocytes by omeprazole. 117
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 108
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 103
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 102
Local and systemic immune response to inactivated C. albicans in mice 100
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 97
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 96
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 95
Cytokine response to inactivated Candida albicans in mice 89
Cytokine response to group B streptococcus infection in mice 84
Graft engineering for allogeneic haploidentical stem cell transplantation 82
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 80
Group B Streptococcus induces apoptosis in macrophages 79
Local and systemic immune response to inactivated Candida Albicans in mice. 75
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 75
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 75
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 74
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 73
Inibizione della attività NK da parte dell’omeprazolo 72
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 72
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 71
Silica particle size and shape: in vitro effects on extracellular matrix metabolism and viability of human bronchial epithelial cells. 71
Regolazione redox dell'apoptosi di linfociti B umani. 69
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 68
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 67
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 66
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 65
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 65
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 64
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 63
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 62
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 61
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 60
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 59
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 57
In vivo generation of LAK-like cells by inactivated Candida albicans cells. 57
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 57
Macrophage apoptosis induced by Group B Streptococcus 57
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 57
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 55
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 55
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 55
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 54
B-chronic lymphocytic leukemia cells exert in vitro cytotoxicity mediated by tumor necrosis factor alpha. 53
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 53
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 53
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function. 51
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 50
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 50
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 50
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. 48
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 48
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 48
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 47
Group B streptococci persist inside macrophages. 46
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 46
Citochine infiammatorie in risposta alla C. albicans inattivata 45
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 45
Una mannoproteina parietale di C. albicans come modulatore in vivo dell'attività delle cellule NK/LAK 42
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 42
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of candida albicans. 40
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 40
Artrite cronica sperimentale indotta nel topo mediante infezione sistemica con Streptococco di Gruppo B, Sierotipo IV 40
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. 39
Modulazione in vivo dell’attività NK/LAK mediante una mannoproteina parietale di C. albicans 39
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 39
Cytokine response to group B streptococcus infection in mice 38
null 37
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 37
Omeprazole inhibition of natural killer cytotoxicity 36
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 35
Persistent in vivo activation of NK/LAK cells by inactivated C. albicans and its mannoprotein fraction 35
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 35
Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole 32
Componenti di parete della C. albicans come induttori di cellule NK e LAK 31
Experimental septic arthritis induced by type IV Group B Streptococcus in mice. 30
Natural mechanism of resistance to Group B Streptococcus (GBS) type Ia infection in mice. 30
Septic arthritis induced in mice by systemic infection with different serotypes of Group B Streptococci (GBS). 30
Pathogenic effects of group B streptococcus on macrophages 30
Patogenicità nel topo di diversi ceppi di Streptococcus di Gruppo B Sierotipo IV 30
C. albicans cell wall components as inducers of LAK-like cells in mice 30
NOTCH and Graft-Versus-Host Disease 30
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 29
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans. 28
Immunomodulatory activity of C. albicans and its cell wall components on LAK-like cells induction in mice. 28
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 27
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation 27
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 26
Una mannoproteina di parete di C. albicans come modulatore in vivo dell’attività delle cellule NK/LAK 26
Produzione in vivo di citochine da parte della C. albicans inattivata ed induzione di cellule NK/LAK 26
Induzione di cellule NK e LAK in vivo: confronto fra la C. albicans ed alcuni "biological response modifiers" 25
Modulazione in vivo dell'attività LAK da parte di alcuni componenti parietali della C. albicans 25
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 23
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 23
Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo 23
Induzione di cellule NK/LAK da parte della C. albicans (CA) e dell' IL-2 nel topo 21
Meccanismi naturali di resistenza verso l'infezione nel topo con Streptococco di Gruppo B (GBS) sierotipo Ia 20
Induzione di effettori della citotossicità naturale da parte della C. albicans: confronto con altri immunomodulatori 20
Totale 5.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 37 2
2019/2020425 18 5 50 10 39 19 64 6 91 71 11 41
2020/20211.037 8 72 59 69 249 93 51 4 108 52 65 207
2021/20221.217 51 287 21 109 49 12 16 293 18 57 125 179
2022/20231.734 117 238 13 181 154 199 13 86 652 0 51 30
2023/2024510 35 79 48 28 4 20 189 23 65 18 1 0
Totale 5.695